Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Optronix is a private UK company that develops and commercializes fiber-optic systems for measuring tissue oxygenation, blood flow, and related physiological parameters in research and clinical settings. The company is best known for oxygen-sensing and perfusion-monitoring instruments used in preclinical studies, translational research, and certain intraoperative or bedside monitoring applications. Its offerings are oriented toward physiological measurement and diagnostics rather than therapeutic drug development, so it does not appear to maintain a conventional drug pipeline. For biotech and medtech analysts, Oxford Optronix is best understood as a niche life-science instrumentation and monitoring company focused on tissue hypoxia, perfusion, and microvascular assessment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Optronix.